| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |